2,225
Views
8
CrossRef citations to date
0
Altmetric
Original Article

System impact research – increasing public health and health care system performance

Pages 211-215 | Received 28 Oct 2015, Accepted 13 Feb 2016, Published online: 15 Mar 2016

Abstract

Background Interventions directed to system features of public health and health care should increase health and welfare of patients and population.

Aims To build a new framework for studies aiming to assess the impact of public health or health care system, and to consider the role of Randomized Controlled Trials (RCTs) and of Benchmarking Controlled Trials (BCTs).

Methods The new concept is partly based on the author's previous paper on the Benchmarking Controlled Trial. The validity and generalizability considerations were based on previous methodological studies on RCTs and BCTs.

Results The new concept System Impact Research (SIR) covers all the studies which aim to assess the impact of the public health system or of the health care system on patients or on population. There are two kinds of studies in System Impact Research: Benchmarking Controlled Trials (observational) and Randomized Controlled Trials (experimental). The term impact covers in particular accessibility, quality, effectiveness, safety, efficiency, and equality.

Conclusions System Impact Research – creating the scientific basis for policy decision making - should be given a high priority in medical, public health and health economic research, and should also be used for improving performance. Leaders at all levels of health and social care can use the evidence from System Impact Research for the benefit of patients and population.

    Key messages

  • The new concept of SIR is defined as a research field aiming at assessing the impacts on patients and on populations of features of public health and health and social care systems or of interventions trying to change these features.

  • SIR covers all features of public health and health and social care system, and actions upon these features. The term impact refers to all effects caused by the public health and health and social care system or parts of it, with particular emphasis on accessibility, quality, effectiveness, adverse effects, efficiency, and equality of services.

  • SIR creates the scientific basis for policy decisions. Leaders at all levels of health and social care can use the evidence from SIR for the benefit of the patients and the population.

Background

The foremost aims in public health and in health and (integrated) social care are to increase effectiveness, safety, efficiency, and equality of the system (Citation1,Citation2). In clinical research most studies aim at assessing effectiveness of a particular intervention targeted at the patient or the population. However, systems guiding the clinical work, as well as the (policy related) interventions to make changes in the system, pursue the same aim: to generate beneficial impact for the patients and for the population. Thus, besides interventions directed to the individuals, also interventions targeted at the public health or at the health and social care system should be subjected to systematic research in order to get evidence of their impact (Citation3). This evidence should be considered when solving the complex issues related to evidence based policy making (Citation4–6).

The aims of this paper are firstly, to consider the need for the new concept of System Impact Research (SIR); secondly, to provide a definition of SIR, and to describe the main categories of SIR; thirdly, to provide examples of SIR, and fourthly, to find a simple way to formulate the study question in SIR, and finally, to consider the validity and generalizability of findings from the two methods within SIR: the Benchmarking Controlled Trials (BCTs) and the Randomized Controlled Trials (RCTs).

Methods

The author has in a previous paper presented the novel concept BCT, which covers all observational effectiveness research, and can be used to answer clinical or system related study questions (Citation3). However, also RCTs may provide evidence of impacts of health and social care system on patients or population. Usually cluster randomization is needed to ensure similarity in system features other than that which is under study between the study arms (Citation7).

Evidence-based medicine framework was used for the formulation of a simple way of presenting the study question in SIR (Citation8,Citation9). In this framework for clinical interventions a PICOS-type study question is formed. PICOS stands for Patient or Population, Intervention, Control intervention, Outcome, and Study design.

The issues of methodological validity and generalizability of the results in SIR were based on previous methodological considerations of RCTs (Citation10–13) and of recommendations for cluster RCTs (Citation7) and for the BCTs (Citation3).

Results

Need to a novel concept and its definition

Hitherto there has been no common concept and its operationalization for studies assessing the impact of public health and health and social care system interventions to the patient or population. Thus there is an obvious need for a novel concept for this purpose.

SIR is defined as a research field aiming at assessing the impacts on patients or on population of features of public health and health and social care systems, or of interventions trying to change these features. SIR covers all features of public health and health and social care system and actions upon these features. The term impact refers to all effects caused by the public health and health and social care system or parts of it, with particular emphasis on accessibility, quality, effectiveness, safety, efficiency, and equality of services. The term research refers to the conceptual basis of the concept, and the BCTs and RCTs are the means to achieve as non-biased evidence as possible to broaden the evidence base of SIR.

SIR includes all studies assessing performance of the health care or public health systems () (Citation13). In many of the categories there are study questions that can be tested both with BCTs and with RCTs. However, some study objects are not feasible for RCTs, but all can be studied by BCTs. In most cases of RCTs the unit of randomization is that of an organization, not the patient or client, and the design is accordingly of a cluster RCT. Similarly also in BCTs, the study design is targeted at organizations, not the individuals, even when the goal is to obtain individual level outcome data.

Figure 1. System Impact Research includes all studies assessing performance of the health care or public health systems. All study objects are feasible for Benchmarking Controlled Trials, while many cannot be studied using a Randomized Controlled Trial design. The Clinical Impact Research is placed in the bottom right corner of the figure only to illustrate another category of impact research; i.e. that of assessing impact of interventions targeting individuals.

Figure 1. System Impact Research includes all studies assessing performance of the health care or public health systems. All study objects are feasible for Benchmarking Controlled Trials, while many cannot be studied using a Randomized Controlled Trial design. The Clinical Impact Research is placed in the bottom right corner of the figure only to illustrate another category of impact research; i.e. that of assessing impact of interventions targeting individuals.

illustrates how to formulate the study question of SIR using the PICOS (Population, Index System, Comparator System, Outcome, Study design) – framework. The most important impact measures are related to these concepts: accessibility, quality of the services (particularly congruence with the current scientific evidence), effectiveness (including patient experience), safety, efficiency and equality (of obtaining effective services of uniform quality).

Figure 2. Shaping the study question of the System Impact Research (SIR) according to PICOS (Population, Index System, Comparator System, Outcome, Study design) -framework. The most important outcome measures are related to six concepts: accessibility, quality of the services (particularly according to scientific evidence), effectiveness (including patient experience), safety, efficiency and equality (of obtaining effective services of uniform quality).

Figure 2. Shaping the study question of the System Impact Research (SIR) according to PICOS (Population, Index System, Comparator System, Outcome, Study design) -framework. The most important outcome measures are related to six concepts: accessibility, quality of the services (particularly according to scientific evidence), effectiveness (including patient experience), safety, efficiency and equality (of obtaining effective services of uniform quality).

The methodological issues in SIR are related to the study question and design, clinical characteristics and system features (). The first five items of the system features are related to the health and social care services and costs. The sixth item contains four levels; staff competence, use of current scientific evidence (evidence based medicine framework), assessment of performance and quality improvement, and benchmarking one’s performance with the peers to improve the performance. These items originate from the real-effectiveness medicine framework (Citation2). Examples of BCTs and of a cluster RCT using the PICO framework are shown in (Citation14–20).

Table 1. Methodological issues in the system impact research (SIR) in benchmarking controlled trials (BCTs) and (cluster) randomized controlled trials (RCTs).

Table 2. PICOS (population, index system, comparator system, outcome, and study design) in system impact research. Some examples from benchmarking controlled trials (BCTs) and (cluster) randomized controlled trials (RCTs).

Discussion

The author’s idea was that there is a need for a framework aiming at assessing the impact of public health features, and health and social care system or parts of it, as well as that of interventions intended to change the system for the benefit of the patients or population. To authors’ knowledge no such framework has been hitherto published.

This paper presents the concept of SIR, which covers both impact research categories, the observational, i.e. BCT and the experimental, i.e. RCT. The strengths and weaknesses of RCTs have been studied extensively and current recommendations on planning, conducting and reporting RCTs have an ample scientific background (Citation21). On the contrary, observational effectiveness studies do not have this background, as prior to the recent paper on BCTs (Citation3) no definition for these studies have existed, and neither criteria on how to appraise them.

RCTs are acknowledged as studies providing the least biased information of the effectiveness of interventions; usually of single interventions under optimal (experimental) circumstances (Citation10). Observational intervention studies aim at assessing effectiveness under ordinary (non-experimental) health care circumstances. The latter studies utilize comparisons between peers, health care providers treating similar patients, and therefore these studies are named the BCTs (Citation1,Citation2).

Major differences between BCTs and RCTs in the risk of bias of the study are related to the consequences of selection of patients. In the former, patients entering the study in each treatment arm may differ at baseline due to selection, while in the latter random allocation to treatment arms leads (regardless of selection) usually to comparable treatment groups (Citation3,Citation10).

Because the unit of randomization in studies aiming at assessing effectiveness of a system is usually that of an organization, not the patient, the design in RCTs is accordingly usually of a cluster randomized trial. Similarly also in BCTs, the study objects are usually organizations, not the individuals, even when the goal is to obtain individual level outcome data. The hypothesis is that changes in the organization lead to favorable impacts for the patients.

When assessing impact of interventions targeting the public health or health care system there are four major challenges. Firstly, particularly in case of BCTs, sufficient data is needed to obtain information indicating whether (particularly) the health care system factors (e.g. related to an economic incentive) may have led to selection of patients and thus to differences in baseline characteristics. The second challenge, principally in case of BCTs, is to adjust for differences in baseline characteristics between the comparators. Third challenge, again particularly for BCTs, is to obtain data of the patients’ clinical pathways to tell in what degree the intervention targeting the system may have changed the pathway and the way patients are treated. The fourth challenge, both for BCTs and RCTs, is to ensure valid and comprehensive outcome measurements in the study arms. Fifth challenge, particularly for BCTs, is to ensure comparability of the system related features between the health care providers. For example the baseline comparability of the patients may be adequate but the competence of the staff of the health care provider using the studied intervention may be better than the competence of the personnel of the health care provider using the control intervention. The sixth challenge, both for BCTs and RCTs, is to document all the effects the intervention causes to the health care system including unintended unfavorable effects. This major challenge of observing often unanticipated consequences in a complex system is most difficult to document, and may become evident only after considerable time lapse after the (policy related) intervention (Citation3).

Conclusions

The new concept of SIR is intended to provide guidance for conducting and assessing studies aiming at providing evidence of comparative impacts of public health and health care system features or policy interventions. BCTs and RCTs cover the whole domain of SIR.

When the experiment is directed to the public health or health care system or part of these, the study questions are often similar than questions posed by the decision makers. SIR – creating the scientific basis for policy decisions – should be given a high priority in clinical, public health and health economic research and should be used for improvement activities. The leaders at all levels of public health and health and (integrated) social care can use the evidence from SIR for the benefit of the patients and the population.

Acknowledgements

Seija Puro, is acknowledged for the graphic design of the figures.

Disclosure statement

The author has developed the idea for the paper and has written the manuscript solely. The author declares no support from any organization for the submitted work; no financial relationships with any organization that might have an interest in the submitted work; and no other relationships or activities that could appear to have influenced the submitted work.

References

  • Malmivaara A. On decreasing inequality in health care in a cost-effective way. BMC Health Serv Res. 2014;14:14–79.
  • Malmivaara A. Real-effectiveness medicine-pursuing the best effectiveness in the ordinary care of patients. Ann Med. 2013;45:103–6.
  • Malmivaara A. Benchmarking controlled trial – a novel concept covering all observational effectiveness studies. Ann Med. 2015;47:332–40.
  • Gray M, El Turabi A. Optimising the value of interventions for populations. BMJ. 2012;345:e6192.
  • Brook RH. The end of the quality improvement movement: long live improving value. JAMA. 2010;304:1831–2.
  • Frieden TR. The future of public health. N Engl J Med. 2015;373:1748–54.
  • Campbell MK, Piaggio G, Elbourne DR, Altman DG, CONSORT Group. Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012;345:e5661.
  • Sackett D. Evidence-based medicine. Lancet. 1995;346:1171.
  • Greenhalgh T. How to read a paper. Getting your bearings (deciding what the paper is about). BMJ. 1997;315:243–6.
  • Furlan AD, Pennick V, Bombardier C, van Tulder M, Editorial Board, Cochrane Back Review Group. 2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine (Phila Pa 1976). 2009;34:1929–41.
  • Croft P, Malmivaara A, van Tulder M. The pros and cons of evidence-based medicine. Spine. 2011;36:E1121–5.
  • Malmivaara A, Koes BW, Bouter LM, van Tulder MW. Applicability and clinical relevance of results in randomized controlled trials: the Cochrane review on exercise therapy for low back pain as an example. Spine (Phila Pa 1976). 2006;31:1405–9.
  • Papanicolas ISP, ed. Health system performance comparison. An agenda for policy, information and research. In: Klazinga N, Li L, eds. Comparing health services outcomes. first ed., pp. 157–82. England: Open University Press, McGraw-Hill Education, 2013.
  • Li H, Wei X, Wong MC, Yang N, Wong SY, Lao X, et al. A comparison of the quality of hypertension management in primary care between Shanghai and Shenzhen: a cohort study of 3196 patients. Medicine (Baltimore). 2015;94:e455.
  • Sutton M, Nikolova S, Boaden R, Lester H, McDonald R, Roland M. Reduced mortality with hospital pay for performance in England. N Engl J Med. 2012;367:1821–8.
  • Kruis AL, Boland MR, Assendelft WJ, Gussekloo J, Tsiachristas A, Stijnen T, et al. Effectiveness of integrated disease management for primary care chronic obstructive pulmonary disease patients: results of cluster randomised trial. BMJ. 2014;349:g5392.
  • Rajaram R, Chung JW, Jones AT, Cohen ME, Dahlke AR, Ko CY, et al. Association of the 2011 ACGME resident duty hour reform with general surgery patient outcomes and with resident examination performance. JAMA. 2014;312:2374–84.
  • Wallace DJ, Angus DC, Barnato AE, Kramer AA, Kahn JM. Nighttime intensivist staffing and mortality among critically ill patients. N Engl J Med. 2012;366:2093–101.
  • Birkmeyer JD, Finks JF, O'Reilly A, Oerline M, Carlin AM, Nunn AR, et al. Surgical skill and complication rates after bariatric surgery. N Engl J Med. 2013;369:1434–42.
  • Pittet D, Hugonnet S, Harbarth S, Mourouga P, Sauvan V, Touveneau S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet. 2000;356:1307–12.
  • Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.